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SUMMARY
The combination of an E2 ubiquitin-conjugating
enzyme with an E3 ubiquitin-ligase is essential for
ubiquitin modification of a substrate. Moreover, the
pairing dictates both the substrate choice and the
modification type. The molecular details of generic
E3-E2 interactions are well established. Neverthe-
less, the determinants of selective, specific E3-E2
recognition are not understood. There are 40 E2s
and 600 E3s giving rise to a possible 24,000 E3-
E2 pairs. Using the Fanconi Anemia pathway exclu-
sive E3-E2 pair, FANCL-Ube2T, we report the atomic
structure of the FANCL RING-Ube2T complex,
revealing a specific and extensive network of addi-
tional electrostatic and hydrophobic interactions.
Furthermore, we show that these specific interac-
tions are required for selection of Ube2T over other
E2s by FANCL.
INTRODUCTION
Ubiquitination is a reversible posttranslational modification in
which ubiquitin (Ub) is covalently attached via its C terminus,
typically to a substrate lysine. Ubiquitination is required for the
strict regulation of a wide range of essential cellular processes,
from protein degradation to DNA repair and cell-cycle control
(Pickart and Eddins, 2004). Consequently, defects that arise in
the regulation of ubiquitination can lead to a variety of diseases,
such as cancers and neurodegeneration.
Substrate ubiquitination is achieved through an enzyme
cascade involving an E1 activating enzyme, an E2 ubiquitin-
conjugating (UBC) enzyme, and an E3 ligase. The E3 ligase, in
combination with its partnered E2 enzyme, coordinates the
transfer of ubiquitin onto a specific lysine residue. The E3-E2
pair also dictates the type of modification, ranging from monou-
biquitination to Ub polymers (Ye and Rape, 2009). The human
genome encodes two E1 enzymes, approximately 40 E2s and
over 600 E3 ligases, giving rise to thousands of possible permu-
tations of E3-E2 pairings.
Experimentally determined structures of E3-E2 complexes
have revealed a well-conserved hydrophobic interaction sur-
face, encompassing loops 1 and 2 and the first helix of the E2.
(Bentley et al., 2011; Dou et al., 2012; Huang et al., 1999; Plecha-
novova´ et al., 2012; Pruneda et al., 2012; Yin et al., 2009; Zheng
et al., 2000). Furthermore, the conservation of the E2 UBC fold,
along with the conservation of the hydrophobic residues for
the E3-interacting interface, suggests that all E3s could function
with all E2s (van Wijk and Timmers, 2010). Yet, this is not what is
observed in nature, as there is selectivity in E3-E2 pairs with
some pairs being exclusive (Bailly et al., 1994; Chen et al.,
2006). There have been great efforts using yeast-two-hybrid
screens, computational biology, and modeling methods to
determine E3-E2 pairs (Kar et al., 2012; Markson et al., 2009;
van Wijk et al., 2009). A recent proteome scale modeling study,
aimed at identifying determinants of E3-E2 specificity, predicts
residues on loop 1 of the E2 to be important for E3 selection
(Kar et al., 2012). Additionally, there is much interest in creating
new E3-E2 pairs or enhancing specificity (Starita et al., 2013;
Winkler and Timmers, 2005), both for understanding ubiquitin
biology and from a therapeutic perspective. However, these
aims are hampered by the lack of molecular details and struc-
tural data as to what constitutes a specific E3-E2 pair.
An example of an exclusive E3-E2 pair is the catalytic center of
the Fanconi Anemia (FA) pathway, FANCL-Ube2T (Alpi et al.,
2008; Machida et al., 2006). The FA pathway is required for
DNA interstrand crosslink repair. Mutations in the FA pathway
result in the genetic disorder known as Fanconi Anemia, where
patients have high predispositions to cancers because of their
genomic instabilities (Alter, 1996). FANCL is a monomeric
RING E3 ligase (Cole et al., 2010; Meetei et al., 2003), which spe-
cifically interacts with the E2, Ube2T (Alpi et al., 2008; Machida
et al., 2006), for the strict monoubiquitination of FANCD2 (Gar-
cia-Higuera et al., 2001; Timmers et al., 2001). This monoubiqui-
tination event is key in signaling the recruitment of downstream
DNA repair factors (Kottemann and Smogorzewska, 2013).
RESULTS AND DISCUSSION
FANCL and Ube2T coelute as a 1:1 stoichiometric complex by
size-exclusion chromatography and have an affinity with a disso-
ciation constant (KD) of 0.5 mM (Hodson et al., 2011). The
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complex crystallizes with a diffraction limit of 11 A˚. In order to
obtain high-resolution data to observe the interface, we fused
human Ube2T to the C terminus of the human FANCL RING
domain with a linker between the proteins. Subsequently, we
determined the structure for the E3-E2 pair, the FANCL RING
domain (residues 299–373), and Ube2T (residues 1–153) to
2.4 A˚ resolution (Figure 1A; Table 1).
The human RING domain contains two zinc atoms coordi-
nated by a (Cys)4, His, (Cys)3 arrangement in a cross-brace
structure. The arrangement of cysteine and histidines differs
slightly to the (Cys)3, His, (Cys)4 arrangement observed in other
RING domains. This unusual arrangement is also noted in the
Drosophila FANCL structure (Cole et al., 2010) and is conserved
Figure 1. Overall Structure of FANCL-
Ube2T Complex
(A) The overall structure of the RING domain of
FANCL (magenta) bound to Ube2T (blue) is shown
in cartoon representation. Gray spheres represent
zinc ions. A gold star represents the position of
Ube2T’s catalytic cysteine.
(B) RING domain of FANCL (magenta) overlain
with c-cbl RING domain (green; PDB ID code
1FBV).
(C) Ube2T (blue) overlain with Ube2L3 (orange;
PDB ID code 1FBV) showing the structural con-
servation of the UBC fold, comprising a four-
stranded b-meander flanked by an N-terminal
helix (helix1) and two C-terminal helices (helixes 2
and 3). A gold star represents the position of the
catalytic cysteine. The gray oval shows the E3
binding interface of E2s.
(D) Top left panel: The pi stacking in the binding
interface between Y311 of FANCL and R6 and R9
of Ube2T. Top right panel: The hydrophobic
binding interface of the RING domain (magenta)
and Ube2T (blue). Bottom panels: The electro-
static and hydrogen bonding network of the RING-
Ube2T interface. Interactions are represented by
dashed lines.
See also Figure S1.
across all other FANCL homologs. An
overlay with the Drosophila FANCL
RING domain reveals that the homologs
are highly similar with a root-mean-
squared deviation (rmsd) of 1.7 A˚ across
all alpha-carbon atoms (Figure S1A avail-
able online). In common with other RING
domains, FANCL contains the helical
element involved in E2 recognition (Fig-
ure 1B) (Deshaies and Joazeiro, 2009).
In complex with FANCL, Ube2T adopts
a typical UBC-fold comprising a four-
stranded beta meander, flanked by an
N-terminal helix and two C-terminal
helices (Figure 1C). In order to deter-
mine whether significant conformational
changes occur in Ube2T upon RING
binding, we superimposed the bound
Ube2T in our structure to unbound
Ube2T (Protein Data Bank [PDB] ID code 1YH2) (Sheng et al.,
2012). The two structures align with an rmsd of 0.67 A˚ across
all alpha-carbon atoms, indicating that no major structural rear-
rangements occur upon complex formation (Figure S1B).
The interface between the RING domain and Ube2T buries a
total surface area of700 A˚2. In commonwith other E3-E2 struc-
tures, the interface consists of a conserved hydrophobic inter-
face between Pro62, Phe63, and Pro100 of Ube2T and Ile309,
Trp341, and Pro360 of FANCL (Figure 1D), as observed in other
RING-E2 structures (Bentley et al., 2011; Dou et al., 2012; Ple-
chanovova´ et al., 2012; Pruneda et al., 2012; Yin et al., 2009;
Zheng et al., 2000). However, the hydrophobic surface of FANCL
is extended by Tyr311, which is involved in pi stacking between
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Arg6 and Arg9 (Figure 1D). Further analysis of the interface re-
veals an extensive electrostatic and hydrogen bonding network
between residues Ser5, Arg6, Arg9, Arg60, Arg99, Ser101, and
Asn103 of Ube2T and Asp306, Tyr311, Glu340, and Ser363 of
FANCL, with additional main-chain interactions with Ile309,
Cys310, and Tyr361 of FANCL (Figure 1D).
Structure-based alignments reveal conservation of the resi-
dues attributable to the hydrophobic interface across RING
domains and E2s (Figure 2). Based on our observations, we hy-
pothesized that not only the conserved hydrophobic residues
Ile309 and Trp341, but also the FANCL-specific Tyr311 revealed
by our structure, are important for the FANCL-Ube2T interaction.
To test this hypothesis, we purified single RING-point mutants
Ile309Ala, Tyr311Ala, and Trp341Ala. In contrast to wild-type
(WT) RING, each single-point mutant fails to form a complex
with Ube2T (Figure 3A). Interestingly, our structure-based
alignments reveal the residues involved in the electrostatic and
hydrogen-bonding network observed in the FANCL-Ube2T
interface are highly variable (Figures 2A and 2B). This suggests
that these interactions are specific to this pair. Therefore, we
assessed other E2s for their ability to bind FANCL. We tested
Ube2L3, Ube2D3, Ube2L6, Ube2R1, Ube2K, Ube2H, and
Ube2B, all of which possess the conserved hydrophobic inter-
face residues (except Ube2B, which has an asparagine at posi-
tion Phe63 of Ube2T) but are not conserved in the residues
responsible for the electrostatic and hydrogen bonding network
(Figure 2A). In contrast to Ube2T, none of the other E2s were
competent to complex with FANCL using analytical size-exclu-
sion chromatography (Figure S2A) and native gel shift assays
(Figure S2B). In addition, Ube2T is unable to complex with
another RING domain, Rbx1 (Figure S2A). Taken together, these
results demonstrate the importance of the additional interactions
for E2-E3 selectivity.
Although FANCL does not form a complex with other E2s, the
conserved nature of the E2 UBC-fold and hydrophobic interface
suggests the possibility that, in the absence of Ube2T, FANCL
could function with another E2. To test this, we assayed the
monoubiquitination of FLAG-FANCD2 by FANCL with various
E2s (Figure S2C). In contrast to Ube2T (lane 2 of each blot),
none of the other E2s were able to specifically monoubiquitinate
FANCD2. The very promiscuous E2, Ube2D3 (Brzovic and
Klevit, 2006) is capable of polyubiquitinating FANCD2 in the
absence of FANCL (lane 5, Figure S2C). Importantly, the addi-
tion of FANCL (lane 6, Figure S2C) does not change the modifi-
cation to a monoubiquitination event; it also does not enhance
the amount of polyubiquitinated FANCD2. These results further
support the observed promiscuity of Ube2D3 for lysines
(Wenzel et al., 2011).
Our structural and biochemical analyses suggest that, in a
cellular environment with multiple E2s present, FANCL will pref-
erentially select Ube2T. In order to assess FANCL’s E2 selec-
tivity, we incubated the FANCL RING domain with equimolar
amounts of different E2s, Ube2T, Ube2D3, and Ube2L3 and
assessed the ability of FANCL to select Ube2T by analytical
size-exclusion chromatography (Figure 3B). Indeed, FANCL
exclusively formed a complex with Ube2T, as confirmed by
SDS-PAGE analysis of collected fractions and protein identifica-
tion by mass spectrometry (Figure 3B).
It is clear from our results that FANCL preferentially selects
Ube2T. Although FANCL extends its hydrophobic surface for
interaction with Ube2T by Tyr311, the corresponding Ube2T-
interacting residues Arg6 and Arg9 are conserved in some of
the E2s we have tested for FANCL binding and function (e.g.,
Ube2K, Figure 2A). Therefore, the selectivity of FANCL for
Ube2T must be attributed to the electrostatic and hydrogen
bonding interactions, which are highly variable among the E2s
(Figure 2A). In order to test this hypothesis, we incubated puri-
fied mutants of Ube2T Ser5Arg, Arg60Glu, and Arg99Ser/
Ser101Arg with the wild-type FANCL RING domain and as-
sessed interaction by size-exclusion chromatography. Only
the Arg60Glu mutant of Ube2T is unable to bind the FANCL
RING domain (Figure 4A). Consistent with the binding profile
of Ube2T mutants, Ser5Arg-Ube2T, Arg99Ser/Ser101Arg-
Ube2T, and wild-type Ube2T all support FANCL-dependent
monoubiquitination of FANCD2 (Figure 4B). By contrast,
Arg60Glu-Ube2T is unable to either bind FANCL or facilitate
FANCD2 monoubiquitination (lane 8, Figure 4B). We therefore
conclude that the positive selector in Ube2T for FANCL is
Arg60, which forms a salt bridge with Glu340 of FANCL
(Figure 1D) and is required for FANCL-Ube2T-mediated mono-
ubiquitination of FANCD2.
The dearth of specific E3-E2 structures has hampered the un-
derstanding of how E3s select their E2s. Our structure of FANCL-
Ube2T reveals a specific extensive electrostatic and hydrogen
bonding network surrounding a conserved hydrophobic interac-
tion. In particular, Tyr311 of FANCL, which is a highly variable
residue in other E3s, acts like a key in a lock, pi stacking between
Arg6 and Arg9 of Ube2T. Additionally the nonconserved Asn103
of Ube2T further anchors Tyr311 of FANCL into position. Ser5 of
Ube2T acts as a negative selectivity factor: as in other E2s it is a
Table 1. Data Collection and Refinement Statistics
Data Collection
Beamline I24 (DLS)
Wavelength (A˚) 0.96
Resolution range (A˚) 46.8–2.4 (2.5–2.4)
Space group P43212
Cell dimensions (A˚) a = 109.3, b = 109.3, c = 117.7
Cell dimensions () a = 90, b = 90, g = 90
Unique reflections 28,423
Multiplicity 6.8 (7.2)
Completeness (%) 100 (100)
Rmeas (%), Rpim (%), CC1/2 13.8 (81.1), 5.6 (45.1), 0.99 (0.47)
<I/s> 5.7 (1.2)
Refinement
PDB ID code 4CCG
Rwork / Rfree 21.2/24.8
No. of non-H atoms 3,744
Mean B value (A˚2) 61.6
Rmsd bond lengths (A˚) 0.004
Rmsd bond angles () 0.670
MolProbity clashscore 2.52
Highest-resolution shell is given in parentheses. Rmsd, root-mean-
square deviation.
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Figure 2. Structural Comparison of the FANCL RING Domain-Ube2t Complex with Other RING-E2 Complexes
(A) A structure-based sequence alignment of E2s. PDB ID codes of E2s, as listed in the figure: 1FBV, 3RPG, 4AP4, 4AUQ, 3RZ3, 2YB6, 3K9O, 3H8K, 2Z5D, 2F4W,
3HCT, and 3BZH.
(B) A structure-based sequence alignment of RING and Ubox domains. Ubox domains are highlighted by a cyan box. PDB ID codes used of RING and Ubox
domains, as listed in the figure: 1FBV, 4F52, 4AUQ, 3HCT, 2C2V, 3LIZ, 3RPG, 4AP4, 4EPO, 2YHO, 2Y43, 4KBL, and 4K7D. Residues shaded in red to yellow
colors indicate conserved residues, where red corresponds to strict conservation. Gray bars indicate zinc coordinating atoms. Green circles highlight residues
involved in the hydrophobic interface between FANCL and Ube2T. Purple circles denote residues involved in hydrogen bonding and electrostatic interactions in
the FANCL Ube2T interface.
(C) Superpositions of the FANCL RING-Ube2T complex (colored pink and blue, respectively), with c-cbl RING-Ube2L3 complex (left) shaded gray (PDB ID code
1FBV), idol-Ube2D1 complex (middle) shaded gray (PDB ID code 2YHO), and ring1b-Ube2D3 complex (right) shaded gray (PDB ID code 3RPG). Numbered
residues are the same as the FANCL RING-Ube2T complex, with dashed lines showing interactions.
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much larger, bulkier residue and is typically arginine or lysine.
These residues would result in loss of the hydrogen bond that
occurs between Ser5 of Ube2T and the main chain oxygen of
Cys310 of FANCL and potentially clash with FANCL residues
Cys310 or Ala312 and/or the main chain of Gln314. Importantly,
we have identified Arg60 of Ube2T as the positive selector for
FANCL (Figures 1D, 2A, and 4). In other E2s, the equivalent po-
sition frequently has the opposite charge (Glu in Ube2L3, Asp in
the Ube2D family, and Glu in Ube2B). Ube2E1 and Ube2E2 have
97% sequence identity and share common E3s but also have
distinct E3 partners. The residue equivalent to Arg60 in Ube2T
is predicted to be important for this distinction in a recent prote-
ome-scale modeling study (Kar et al., 2012). Our study provides
Figure 3. Conserved Hydrophobic RING
Residues Are Required for Ube2T Binding
and FANCL Selects Solely Ube2T In Vitro
(A) Size-exclusion chromatogram profiles of wild-
type (WT) or mutant RING domains (green dashed
line) and WT Ube2T (blue dotted line) overlaid with
profiles from binding experiments in which WT
Ube2T has been incubated with WT or mutant
RING domains (pink line) and subjected to size-
exclusion chromatography. Binding was assessed
by complex formation, which is indicated by a
peak shift to the left labeled complex.
(B) Size-exclusion chromatogram of FANCL RING
domain incubated with an E2 mix consisting of
Ube2T, Ube2D3, and Ube2L3 (pink line). Chro-
matograms of Ube2T (blue dotted line) and the
RING domain (green dashed line) are also overlaid.
A peak shift to the left is observed, indicating
complex formation. SDS-PAGE gel of the fractions
collected from the size-exclusion experiment and
stained with Coomassie Brilliant Blue. The E2 gel
bands found in the shifted peak were assessed by
mass spectrometry for protein identification and
confirmed as exclusively Ube2T.
See also Figure S2.
experimental support for the importance
of this position in a more divergent E2.
Arg60 of Ube2T forms a salt bridge with
Glu340 of FANCL (Figure 1D). In other
E3s, the equivalent residue is poorly
conserved (Figure 2B).
Our structural and biochemical data
can be used to refine algorithms for pre-
dicting E3-E2 pairs and provide a drug-
gable platform for the development of
chemotherapeutics.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
To generate the RING-linker-Ube2T fusion
construct, we cloned human FANCLRING domain
(residues 289–375) from synthetic human FANCL
DNA (GeneArt) codon-optimized for Escherichia
coli expression and inserted N terminally to
Ube2T encoded in a vector containing a N-termi-
nal 6xHis-Smt3 tag, by restriction-free cloning
(RF) (van den Ent and Lo¨we, 2006). A 14 amino
acid (TGSTGSTETGYTQG) linker was inserted between the C-terminal of the
RING domain and N-terminal of Ube2T (Pellegrini et al., 2002) by Phusion
site-directed mutagenesis. Human Ube2T, Mouse Rbx1, and Xenopus tropi-
calis FANCL were cloned from I.M.A.G.E clones (Geneservice) into a vector
containing a 6x His-Smt3 tag by RF methods. The Human FANCL RING
domain (residues 289–375) was cloned from the synthetic human FANCL
DNA as described above. Human Ube2D3 (UbcH5c), Ube2L3 (UbcH7),
Ube2K, Ube2B, and Ube2R1 were cloned from I.M.A.G.E. clones (Geneser-
vice) and inserted into the pDEST17 (Invitrogen) and pET RSF vectors contain-
ing an N-terminal 6xHis tag and a TEV cleavage site. Ube2H was purchased
as a synthetic gene in expression vector pJ441 containing a 6xHis tag and a
TEV cleavage site from DNA 2.0. Proteins were expressed in E. coli BL21 cells
(Invitrogen) or Rosetta (DE3) cells (Millipore) in the case of X. tropicalis
FANCL, Ube2K, and Ube2R1. Cells were cultured in Lysogeny broth (LB)
supplemented with antibiotics and 0.5 mM ZnCl2 for proteins with a RING
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domain, at 37C. Once OD600 had reached 0.6, protein expression was
induced by the addition of 250 mM isopropyl-1-thio-b-d-galactopyranoside
(IPTG) (500 mM in the case of the E2s). Cells were cultured overnight at 16C
and harvested the following day by centrifugation. Harvested cells were lysed
by sonication of 43 10s bursts on ice, in buffer containing 0.5 M NaCl, 0.1 M
Tris (pH 8), 0.02 M Imidazole, and 250 mM tris(carboxyethyl)phosphine
(TCEP). Cell debris was removed by centrifugation at 32,000 3 g. Superna-
tants were added to equilibrated Ni-NTA Agarose (QIAGEN) and incubated
on a roller for 1 hr at 4C. 6xHis-Smt3 tags were removed overnight at 4C
by Ulp1 protease at a w/w ratio of 1:15, Ulp1:protein. Xenopus tropicalis
FANCL was flash frozen at 0.5 mg/ml and stored at 80C. Ube2D3,
Ube2L3, Ube2K, Ube2B, Ube2R1, and Ube2H were eluted from agarose,
and their 6xHis tags were removed with His-TEV protease, added at w/w ratio
of 1:15, His-TEV protease:protein, as an overnight dialysis step at 4C. Sam-
ples were concentrated the following day and loaded onto either a Superdex
75 or Superdex 200 column. Purified fractions were pooled and concentrated
before flash freezing and stored at 80C.
Xenopus laevis
Xenopus laevis FANCD2 plasmid was a kind gift from P. Knipscheer and
J. C. Walter. We modified it to contain a N-terminal FLAG tag and prepared
it as previously described (Knipscheer et al., 2009).
Mouse His-UBE1 was a kind gift from K. Iwai (Sato et al., 2008). It was
expressed in sf9 cells cultured at 27C in sf-900 serum-free media (GIBCO)
supplemented with antibiotics. Cells were harvested 3 days postinfection
and lysed by sonication, 23 5 s bursts in buffer containing 0.05 M Tris
(pH 8), 0.1 M NaCl, 0.5 mM PMSF, and 1 mM EDTA. Cell debris was removed
by high-speed centrifugation, 32,000 3 g, and supernatants were added
to equilibrated Ni-NTA Agarose. The His-UBE1 was then eluted from the
agarose, concentrated, and applied to a Superdex 200 column. Purified
His-UBE1was then flash frozen and stored at 80C.
Human RING, Ube2T, and Xenopus laevis FANCD2mutants were generated
using site-directed mutagenesis and expressed as WT proteins.
Figure 4. Additional Residues of Ube2T Are
Required for Binding the RING Domain of
FANCL
(A) Size-exclusion chromatogram profiles of
wild-type (WT) or mutant Ube2T (blue) dotted
line and WT RING domains (green dashed line)
overlain with profiles from binding experiments
in which WT RING domain has been incubated
with WT or mutant Ube2T (pink line) and
subjected to size-exclusion chromatography.
Binding was assessed by complex formation
indicated by a peak shift to the left.
(B) An anti-HA-Ub western blot of in vitro
monoubiquitination assays to assess mono-
ubiquitination of FLAG-FANCD2 by FANCL in
collaboration with different WT Ube2T and
Ube2T mutants (Ube2TArg99Ser/Ser101Arg,
Ube2TSer5Arg, and Ube2TArg60Glu). Lanes 2,
4, and 6 show the monoubiquitination of FLAG-
FANCD2 when WT Ube2T, Ube2T Arg99Ser/
Ser101Arg, and Ube2TSer5Arg are paired
with FANCL. Monoubiquitination is not observed
for with the Ube2TArg60Glu mutant is used
(lane 8).
Crystallization and Structure
Determination
The RING-Ube2T fusion crystals were grown
using a final concentration of 11.7 mg/ml by
sitting drop vapor diffusion at 4C in spacegroup
P43212 with cell dimensions of a = 109.3 A˚, b =
109.3 A˚, c = 117.7 A˚, a = 90, b = 90, and g =
90. Crystallization conditions were 1.6 M
ammonium sulfate, 0.1 M NaCl, 0.1 M HEPES (pH 7.5). Crystals were cryo-
protected with 20% glycerol and cryocooled in liquid nitrogen. Data were
collected at Diamond Light Source on the microfocus I24 beamline at
0.96 A˚ wavelength. Data were processed using D*trek (Pflugrath, 1999),
showing diffraction to 2.25 A˚ resolution. An estimated solvent content of
52.7% suggested two copies of the polypeptide chain in the asymmetric
unit (ASU). Phases were generated by molecular replacement using the pro-
gram Phaser (McCoy et al., 2007) with Ube2T (residues 1–154, PDB ID code
1YH2) and Drosophila FANCL (residues 312–371, 3K1L) (Cole et al., 2010) as
search models. The model was refined iteratively using phenix.refine (Afo-
nine et al., 2005) and manual model building using Coot (Emsley and Cow-
tan, 2004). Data were cut off to 2.4 A˚ resolution, and the last 400 images
were omitted because of radiation damage. Omit maps were generated to
check for model bias. The final model’s stereochemistry and geometry
was checked with MolProbity (Davis et al., 2004) analysis (Table 1) and
for favored regions of the Ramachandran plot (97.52%). Table 1 summarizes
data collection and refinement statistics. The ASU contains four chains, two
chains of Ube2T (A and B), and two chains of FANCL RING domain (X and
Y). In both chains of Ube2T, electron density was not observed for the C-ter-
minal (residues 154–197), and for chain B, the loop region from residue
27–32 was not modeled because of poor electron density. For chain Y of
the RING domain, residues 352 and 353 were not modeled because of a
symmetry contact leading to poor electron density. Additionally, there was
no observed electron density for the majority of the fusion linker. The
RING domain, chain X interacts with chain A of Ube2T, and the RING
domain chain Y interacts with chain B of Ube2T. Also, Arg9 in chain A is
not seen in the interaction interface because of its displacement by a
symmetry molecule.
Structural Analysis
All structural analyseswere carried out using PyMOL (Delano, 2002). Structural
alignments were produced and manually adjusted using MegAlign software.
The structural interface was calculated using PISA.
Structure
Structure of the FANCL RING-Ube2T Complex
342 Structure 22, 337–344, February 4, 2014 ª2014 The Authors
Analytical Size-Exclusion Chromatography
Interactions between RING domains and E2s were assessed by analytical
size-exclusion chromatography, as described previously (Hodson et al.,
2011). Briefly, interactions were incubated in buffer containing 0.1 M NaCl,
0.1 M Tris (pH 8), and 250 mM TCEP in a total volume of 500 ml and left on
ice for 1 hr. Samples were loaded onto a Superdex 75 10/300 column (GE
Healthcare), and 0.5 ml fractions were collected. Fractions were analyzed on
12% SDS-PAGE gels.
Native Gel Assays
Interactions between FANCL RING domain and E2s were assessed by native
gel assays. Excess FANCL RING domain (140 mM) was incubated with
80–100 mM of E2 and incubated in buffer containing 0.1 M NaCl, 0.1 M Tris
(pH 8), and 250 mM TCEP in a total volume of 10 ml and left on ice for
10 min. A 10 ml of loading buffer containing 10% glycerol was added to
the samples, and the samples were analyzed on 4%–12% native PAGE gels
(Invitrogen). Gels were stained with SimplyBlue SafeStain (Invitrogen).
FANCD2 Monoubiquitination Assay
The ability of FANCL to monoubiquitinate FANCD2 using different E2s was as-
sessed by an in vitro monoubiquitination assay. Reaction volumes of 25 ml con-
tained17nMHis-UBE1,0.64mME2, 1.86mMXenopus tropicalisFANCL, 4.2mM
HA-Ub (Boston Biochem), 0.5 mM Xenopus laevis FLAG-FANCD2 or FLAG-
FANCD2K562R, and reaction buffer: 50 mM Tris (pH 7.5), 100 mM KCl2, 2 mM
MgCl2, 0.5 mM DTT, and 2 mM ATP. Ube2D3, Ube2L6, and Ube2N/Ube2V1
were purchased from Boston Biochem. Reactions were left for 1.5 hr at room
temperature. A 25 ml volume of LDS buffer (Invitrogen) containing BME was
used to terminate reactions. Samples were loaded onto a 4%–12% SDS-
PAGE gel and subjected to western blotting. Anti-HA antibody, raised against
HA peptide (Pettinghill Technology), anti-FLAG antibody (Abcam), and anti-
FANCD2 (Abcam), was used to probe for FLAG-FANCD2 monoubiquitination.
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